This announcement is a separate document:
クリングルファーマ：2023年９月期第３四半期決算及び第13回新株予約権発行による資金調達について
Kringle Pharma: Funding through financial results for the 3rd quarter of the fiscal year ending September 2023 and the 13th issue of stock acquisition rights
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.